GENE ONLINE|News &
Opinion
Blog

Aduhelm
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
Aftermath of Biogen’s Alzheimer’s Drug Approval Continues as Some Hospitals, Insurers Refuse Administration
2021-07-18
Biogen’s Controversial Alzheimer’s Drug Wins Historic FDA Approval
2021-06-07
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top